Twice each month the CEA Registry Blog lists recently published cost utility studies and associated papers. 25 papers were listed this time. Here's a few in our areas of research interest:
Eggington S, Valldeoriola F, Chaudhuri KR, et al. The cost-effectiveness of deep brain stimulation in combination with best medical therapy, versus best medical therapy alone, in advanced Parkinson's disease. J Neurol. 2013 Oct 25. [Epub ahead of print] PubMed PMID: 24158271.
Zhuo X, Zhang P, Kahn HS, et al. Cost-Effectiveness of Alternative Thresholds of the Fasting Plasma Glucose Test to Identify the Target Population for Type 2 Diabetes Prevention in Adults Aged >=45 Years. Diabetes Care. 2013 Oct 17. [Epub ahead of print] PubMed PMID: 24135386.
Mezquita Raya P, Pérez A, et al. Incretin Therapy for Type 2 Diabetes in Spain: A Cost-Effectiveness Analysis of Liraglutide Versus Sitagliptin. Diabetes Ther. 2013 Oct 17. [Epub ahead of print] PubMed PMID: 24132613.
Please note: links
are to full-text where available (i.e. open access articles) or to PubMed. ScHARR staff only – if you
require help accessing any of the articles mentioned in this blog, please
contact Kath Dickinson, Information Specialist at ScHARR.